Fertility after treatment for Hodgkin's disease

Zeev Blumenfeld(Rappaport Family Institute for Research in the Medical Sciences), Jacob M. Rowe(Technion – Israel Institute of Technology), Eldad J. Dann(Rambam Health Care Campus), Ron Epelbaum(University of Bern), Irit Avivi(Tel Aviv Sourasky Medical Center)
Annals of Oncology
April 1, 2002
10.1093/annonc/13.s1.138
Cited by 153

Related Papers

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
|Blood|2006|843
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
|Blood|2007|782